About a month ago, ScripsAmerica, Inc. (OTCMKTS:SCRC, SCRC message board) was barely keeping its head above the $0.12 per share mark. Volumes were small and nobody seemed all that interested. Now, though, things are a little bit different.
Red sessions over the last few weeks have been few and far between. SCRC seems to be marching towards the higher end of the charts and if the surge continues, the stock might soon break above the $0.20 per share barrier for the first time since February 2014. Yesterday's closing bell stopped it at a little over $0.19 (an 8% gain on Monday's close). But why did the market's attitude towards the stock change all of a sudden?
We mentioned three weeks ago that SCRC is a relatively solid OTC company and that its balance sheet could make a lot of penny stock enterprises green with envy. The management team seem determined to convince investors that things will get even better in the future.
On December 30, they said that they have managed to pay off around $325 thousand worth of high-interest notes and emphasized on the fact that the credit facility with Triumph Healthcare has much more favorable terms. They also said that they expect 2015 to be “Scripts' most successful year to day”. If a press release from January 5 is to be believed, they might be onto something.
On Monday, SCRC announced that their subsidiary, Main Avenue Pharmacy, has recorded more than $5 million in approved orders for the month of December alone. The Q3 revenues amount to around $12.8 million which means that if the trend continues, the shareholders might see some even more solid financial results in the months to come.
While nothing can be guaranteed, the people running the company appear to be pretty happy about the path that SCRC is on, and the recent stock performance goes to show that investors are ready to follow their lead and jump in.
That doesn't mean, however, that an investment should be undertaken without doing your research and due diligence. And as we mentioned in our previous article, there are one or two things you need to consider carefully before trusting your money with SCRC.
The issuance of stock is perhaps the thing that you should pay most attention to. During the first nine months of last year, SCRC issued more than 9 million shares as a conversion of debt at just $0.07 a piece. A further 27.3 million were sold at an average price of just over $0.05 and although these ones are restricted, once the restriction falls, the people who got them might be eager to let them loose on the open market. And if that happens, SCRC's current levels might become hard to sustain.
About fifty minutes after today's opening bell, the ticker is sitting at $0.199 (2.8% in the green).
Watch the video to learn about the probability of SCRIPSAMERICA, INC. (SCRC) Chart Signal as of Jan 08, 2015
http://www.hotstocked.com/article/88896/scrip...-with.html
Red sessions over the last few weeks have been few and far between. SCRC seems to be marching towards the higher end of the charts and if the surge continues, the stock might soon break above the $0.20 per share barrier for the first time since February 2014. Yesterday's closing bell stopped it at a little over $0.19 (an 8% gain on Monday's close). But why did the market's attitude towards the stock change all of a sudden?
We mentioned three weeks ago that SCRC is a relatively solid OTC company and that its balance sheet could make a lot of penny stock enterprises green with envy. The management team seem determined to convince investors that things will get even better in the future.
On December 30, they said that they have managed to pay off around $325 thousand worth of high-interest notes and emphasized on the fact that the credit facility with Triumph Healthcare has much more favorable terms. They also said that they expect 2015 to be “Scripts' most successful year to day”. If a press release from January 5 is to be believed, they might be onto something.
On Monday, SCRC announced that their subsidiary, Main Avenue Pharmacy, has recorded more than $5 million in approved orders for the month of December alone. The Q3 revenues amount to around $12.8 million which means that if the trend continues, the shareholders might see some even more solid financial results in the months to come.
While nothing can be guaranteed, the people running the company appear to be pretty happy about the path that SCRC is on, and the recent stock performance goes to show that investors are ready to follow their lead and jump in.
That doesn't mean, however, that an investment should be undertaken without doing your research and due diligence. And as we mentioned in our previous article, there are one or two things you need to consider carefully before trusting your money with SCRC.
The issuance of stock is perhaps the thing that you should pay most attention to. During the first nine months of last year, SCRC issued more than 9 million shares as a conversion of debt at just $0.07 a piece. A further 27.3 million were sold at an average price of just over $0.05 and although these ones are restricted, once the restriction falls, the people who got them might be eager to let them loose on the open market. And if that happens, SCRC's current levels might become hard to sustain.
About fifty minutes after today's opening bell, the ticker is sitting at $0.199 (2.8% in the green).
Watch the video to learn about the probability of SCRIPSAMERICA, INC. (SCRC) Chart Signal as of Jan 08, 2015
http://www.hotstocked.com/article/88896/scrip...-with.html
